Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 532067 | NSE Symbol : | ISIN : INE994E01018 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
03-Feb-2025	13-Feb-2025	Quarterly Results	3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on 31st December 2024. Submission of Unaudited Standalone and Consolidated Financial Results for the quarter and nine-months ended 31-12-2024 (As per BSE Announcement Dated on 13/02/2025)
04-Nov-2024	13-Nov-2024	Quarterly Results	3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company. The Board of Directors have considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September 2024 (As Per BSE Announcement Dated on: 13/11/2024)
30-Jul-2024	12-Aug-2024	Quarterly Results	3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the company for the first quarter ended on 30th June2024. Unaudited Standalone and Consolidated Financial Results for quarter ended 30-06-24 (As Per BSE Announcement Dated on: 12/08/2024)
02-May-2024	29-May-2024	Accounts	3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter / year ended March 31 2024. Submission of Audited Financial Results for the Quarter and Financial Year ended 31st March,2024. (As Per BSE Announcement Dated on:29/05/2024)
17-Jan-2024	09-Feb-2024	Quarterly Results	3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December 2023. Outcome Of The Board Meeting- Unaudited Financial Results For The Quarter And Nine Months Ended 31st December, 2023. (As Per BSE Announcement dated on 09.02.2024)
31-Oct-2023	10-Nov-2023	Quarterly Results	KILPEST INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September 2023. Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September, 2023 (As Per BSE Announcement Dated on 10.11.2023) Newspaper Publication (As Per BSE Announcement dated on 11.11.2023)
28-Sep-2023	10-Oct-2023	Scheme of Amalgamation	Allotment of Shares pursuant to Scheme of Amalgamation Outcome of Board Meeting (As Per BSE Announcement Dated on 10/10/2023)
11-Sep-2023	11-Sep-2023	Scheme of Amalgamation	Outcome of Board Meeting under Regulation 30 SEBI (LODR), 2015
21-Aug-2023	29-Aug-2023	Scheme of Amalgamation	KILPEST INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2023 inter alia to consider and approve the Record Date for the purpose of determining the shareholders of 3B BlackBio Biotech India Limited (Transferor Company) to whom equity shares of the Company would be allotted pursuant to the Scheme of Amalgamation.
02-Aug-2023	11-Aug-2023	Quarterly Results	KILPEST INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve the Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2023 Standalone and Consolidated Un-Audited Financial Result for the quarter ended on 30th June,2023 Outcome of Board Meeting (As Per BSE Announcement Dated on 11.08.2023)
25-Apr-2023	29-May-2023	Accounts	KILPEST INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter / year ended March 31, 2023 and to discuss the matter of recommendation of dividend ,if any, for the year ending March 31, 2023. Dividend Update Outcome of Board Meeting (As Per BSE Announcement dated on 29.05.2023)
01-Feb-2023	14-Feb-2023	Quarterly Results	Quarterly Results KILPEST INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 ,inter alia, to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for Quarter and Nine Months ended 31st December, 2022. Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended December 31, 2022 Board Meeting Outcome for Board Meeting Held On Tuesday, 14th February, 2023 (As per BSE Announcement Dated on 14/02/2023)
03-Nov-2022	12-Nov-2022	Quarterly Results	KILPEST INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 inter alia to consider and approve Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September 2022 Un-audited Financial Results for the Half year/Quarter ended 30th September,2022 (As Per BSE Announcement Dated 12.11.2022)
01-Aug-2022	10-Aug-2022	Quarterly Results	KILPEST INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 inter alia to consider and approve the Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2022 Standalone and Consolidated Financial Results for the quarter ended on 30th June, 2022 (As Per BSE Announcement dated on 10.08.2022)
22-Apr-2022	27-May-2022	Quarterly Results	Audited Results KILPEST INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2022 ,inter alia, to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter / year ended March 31, 2022 and to discuss the matter of recommendation of a dividend ,if any, for the year ending March 31, 2022. Outcome of Board Meeting Kilpest India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2022, inter alia, have recommended a final dividend of 25% i.e. Rs. 2.5/- per equity share of face value of Rs. 10/ each for the FY 2021-22 which is subject to approval of the shareholders at the ensuring Annual General Meeting. Audited Financial Results for the Quarter and Financial year ended 31st March,2022 Outcome of Board Meeting Dividend Update (As Per BSE Announcement Dated on 27.05.2022)

1 2

LOGIN HERE

3B Blackbio DX Ltd

Board Meeting